Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pfister

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|April 11, 2018
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published ModelsAndré Dallmann, Marc Pfister, John van den Anker, et al.
Journal of Clinical Pharmacology|April 29, 2011
Optimizing drug development and use in patients with kidney diseaseThomas D Nolin, Vikram Arya, Daniel S Sitar, et al.
Clinical Pharmacokinetics|October 31, 2002
Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic womenJianfeng Lu, Marc Pfister, Paolo Ferrari, et al.
Pharmaceutics|April 28, 2023
Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and ChildrenKlervi Golhen, Michael Buettcher, Jonas Kost, et al.
Journal of Clinical Pharmacology|August 17, 2018
Characterization of Maternal and Neonatal Pharmacokinetic Behavior of CeftazidimeAndré Dallmann, John van den Anker, Marc Pfister, et al.
Pediatric Rheumatology Online Journal|March 26, 2021
Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trialsTatjana Welzel, Carolyn Winskill, Nancy Zhang, et al.
The AAPS Journal|December 16, 2005
Modeling and simulation of adherence: approaches and applications in therapeuticsLeslie A Kenna, Line Labbé, Jeffrey S Barrett, et al.
Journal of Hypertension|January 16, 2002
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockadePaolo Ferrari, Hans-Peter Marti, Marc Pfister, et al.
Clinical Pharmacokinetics|July 23, 2021
Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment RegimenCornelis Smit, Daniela Hofmann, Somphou Sayasone, et al.
Journal of Optimization Theory and Applications|November 1, 2021
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal ControlFreya Bachmann, Gilbert Koch, Marc Pfister, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|April 11, 2018
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published ModelsAndré Dallmann, Marc Pfister, John van den Anker, et al.
Journal of Clinical Pharmacology|April 29, 2011
Optimizing drug development and use in patients with kidney diseaseThomas D Nolin, Vikram Arya, Daniel S Sitar, et al.
Clinical Pharmacokinetics|October 31, 2002
Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic womenJianfeng Lu, Marc Pfister, Paolo Ferrari, et al.
Pharmaceutics|April 28, 2023
Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and ChildrenKlervi Golhen, Michael Buettcher, Jonas Kost, et al.
Journal of Clinical Pharmacology|August 17, 2018
Characterization of Maternal and Neonatal Pharmacokinetic Behavior of CeftazidimeAndré Dallmann, John van den Anker, Marc Pfister, et al.
Pediatric Rheumatology Online Journal|March 26, 2021
Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trialsTatjana Welzel, Carolyn Winskill, Nancy Zhang, et al.
The AAPS Journal|December 16, 2005
Modeling and simulation of adherence: approaches and applications in therapeuticsLeslie A Kenna, Line Labbé, Jeffrey S Barrett, et al.
Journal of Hypertension|January 16, 2002
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockadePaolo Ferrari, Hans-Peter Marti, Marc Pfister, et al.
Clinical Pharmacokinetics|July 23, 2021
Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment RegimenCornelis Smit, Daniela Hofmann, Somphou Sayasone, et al.
Journal of Optimization Theory and Applications|November 1, 2021
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal ControlFreya Bachmann, Gilbert Koch, Marc Pfister, et al.
Pageof 16